Angiex
PrivateLast Round
VC Round
Nov 17, 2025
Total Funding Raised
$48.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Angiex is a biopharmaceutical company that develops vascular-targeted biotherapeutics and nuclear-delivered antibody-drug conjugates for the treatment of solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Angiex Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Angiex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 17, 2025 | ||||
| Series B | Aug 18, 2021 | ||||
| Seed | Jul 27, 2017 | ||||
| Grant | Nov 2, 2016 |
Key People
Founding team and executive leadership
Angiex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paulson Investment Company | VC Round |
| Presight Capital | Series B |
| Starling Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Presented in vivo data for AGX101, a cancer therapy candidate.
- Apr 17, 2026
Presenting preclinical data for AGX101 at the AACR Annual Meeting.
Angiex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Angiex's valuation, stock price, and market status.